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  This study examined whether amifostine (WR-2721) could 
attenuate memory impairment and suppress hippocampal 
neurogenesis  in  adult  mice  with  the  relatively  low-dose 
exposure of acute radiation syndrome (ARS). These were 
assessed using object recognition memory test, the terminal 
deoxynucleotidyl transferase-mediated dUTP nick end-labeling 
assay, and immunohistochemical markers of neurogenesis 
[Ki-67 and doublecortin (DCX)]. Amifostine treatment (214 
mg/kg, i.p.) prior to irradiation significantly attenuated the 
recognition memory defect in ARS, and markedly blocked the 
apoptotic death and decrease of Ki-67- and DCX-positive cells 
in ARS. Therefore, amifostine may attenuate recognition 
memory defect in a relatively low-dose exposure of ARS in 
adult mice, possibly by inhibiting a detrimental effect of 
irradiation on hippocampal neurogenesis.
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  Clinical interest in the consequences of acute full-body 
radiation exposure as a result of a nuclear accident or 
significant partial-body irradiation by radiotherapy is 
increasing. People who experience a single exposure to a 
broad dose range of ionizing irradiation are described as 
having acute radiation syndrome (ARS) [1]. The primary 
consequence of ARS is a transient or permanent depletion 
of proliferating stem cells and/or immature progenitor 
cells in specific tissues [5]. 
Irradiation exposure of the adult brain results in variable 
degrees of cognitive impairment, even though less histological 
injury is apparent [5]. The cognitive deficits are associated 
with inhibition of adult hippocampal neurogenesis in 
experimental animals [5]. The rate of neurogenesis may be 
altered by several factors including age, genetic influence, 
chemicals, and radiation [4-6]. 
  Amifostine (WR-2721) is a thiophosphate prodrug that is 
converted into the radioprotective thiol, N-2-mercaptoethyl- 
1,3-diamino propane (WR-1065) by the action of membrane- 
bound alkaline phosphatase [9]. Amifostine may have free 
radical scavenging properties [7].
  The aim of this study was to analyze whether amifostine 
could attenuate recognition memory impairment and 
inhibition of hippocampal neurogenesis in adult mice with 
a relatively low-dose exposure ARS.
  Forty-one  male,  8-week-old ICR mice (Orient Bio, 
Korea) were used in this experiment. All experimental 
procedures were conducted in accordance with the 
Guidelines for the Care and Use of Laboratory Animals at 
Chonnam National University.
  To observe the effect of amifostine (214 mg/kg, i.p. 30 
min before irradiation) on the recognition memory defect 
in ARS, the experimental groups of mice (n = 7 in each 
group) were sham irradiated (0 Gy; control) or were 
whole-body irradiated with 2 Gy 
60Co gamma-rays using a 
Gamma-cell Elan 3000 (Nordion International, Canada) at 
a dose-rate of 3.1 Gy/min. An object recognition memory 
test representing a hippocampus-dependent learning paradigm 
was performed as previously described [5]. 
  To discern the effect of amifostine on apoptotic cell death 
and the inhibition of neurogenesis in the adult hippocampus 
with ARS, mice (n = 4 mice/group) were sham irradiated 
(control) or whole-body irradiated with 0.5 or 2 Gy. The 
mice were sacrificed 12 h after irradiation, and the brain 
were then dissected from each mouse. 
    Five micron-thick coronal sections of paraffin wax- 
embedded brain were deparaffinized and allowed to react 
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Fig. 1. Pretreatment of amifosine significantly attenuates object recognition memory defects in mice with acute radiation syndrome 
(ARS). The sham controls (sham irradiation of 0 Gy), vehicle controls (vehicle + 2 Gy), and amifostine-treated mice (amifostine + 2
Gy) were examined (n = 7 for each group). *p ＜ 0.05.
Fig. 2. Histological analyses for the sham controls (12 h after sham irradiation of 0 Gy), vehicle-treated, and amifostine-treated mouse
hippocampe 12 h after gamma irradiation of 0.5 and 2 Gy. *p ＜ 0.05, **p ＜ 0.01.
using a monoclonal rabbit anti-Ki-67 antibody (DRM004; 
Acris Antibodies GmbH, Germany) and polyclonal rabbit 
anti-DCX antibody (Cell Signaling Technology, USA), as 
previously described [5].
  The number of cells showing specific characteristics of 
proliferating cells (immunopositive for Ki-67) and immature 
progenitor cells (immunopositive for DCX) in the hippocampi 
was scored by an observer blinded to the identity of the 
sample using a histomorphometric approach [5]. The level 
of DNA fragmentation was detected by in situ nick end- 
labeling (terminal deoxynucleotidyl transferase-mediated 
dUTP nick end-labeling; TUNEL) using an ApopTag in 
situ apoptosis detection kit (Millipore, USA) according to 
the manufacturer’s instructions. 
  The data is reported as mean ± SE and analyzed using 
one-way analysis of variance followed by a Student- 
Newman-Keuls post hoc test for multiple comparisons. In 
all cases, a p value ＜ 0.05 was considered significant.
  In the object recognition memory test, the sham controls, 
vehicle-treated mice, and amifostine-treated mice displayed 
an equal preference to the two objects during training (1 
day after irradiation, Fig. 1A). During testing (1 day after 
training), vehicle-treated mice showed memory deficits in 
the object recognition memory test (p ＜ 0.05 vs. sham Amifostine ameliorates memory defect in ARS    83
controls), whereas amifostine-treated mice did not (Fig. 
1B; p ＜ 0.05, amifostin-treated group vs. vehicle- treated 
group). There was no significant difference in the total number 
of interactions during training between the three groups 
(Fig. 1C), suggesting comparable levels of attention, motivation, 
and visual perception.
  TUNEL-positive apoptotic cells were measured 12 h after 
irradiation (Fig. 2A). In vehicle-treated mice, the number 
of TUNEL-positive cells in the hippocampus significantly 
increased in mice irradiated with gamma ray doses of 0.5 
Gy and 2 Gy. However, pretreatment with amifostine 
markedly blocked the number of apoptotic nuclei in mice 
irradiated with 0.5 Gy (p ＜ 0.05 vs. vehicle-treated mice) 
and 2 Gy (p ＜ 0.01 vs. vehicle-treated mice). 
  Immunhistochemically, Ki-67- (Fig. 2B) and DCX-positive 
cells (Fig. 2C) were constitutively expressed in the DGs of 
adult hippocampi in control mice. Ki-67-positive cells 
significantly declined in the hippocampus 12 h after 
irradiation with gamma ray doses of 0.5 Gy and 2 Gy. 
DCX-positive cells significantly declined in the hippocampus 
12 h after irradiation with 0.5 Gy  and 2 Gy. However, 
amifostine pretreatment markedly increased the number of 
Ki-67-positive cells (p ＜ 0.05 vs. vehicle-treated mice) 
and DCX-positive cells (p ＜ 0.01 vs. vehicle-treated mice) 
only in mice irradiated with 2 Gy (Figs. 2B and C). 
    There is consensus in the literature the inhibition of 
neurogenesis in the DG of the adult hippocampus is 
associated with cognitive impairment, with progenitor 
neural cells being particularly vulnerable to irradiation [8,10]. 
Therefore, it is important to clarify which radioprotective 
agent is effective in rescuing neural stem/ progenitor cells 
in the adult hippocampus from ARS.
  Radiation injury in specific organs is initiated by DNA 
damage and oxidative stress involving reactive oxygen 
species (ROS) [10]. Therefore, substances capable of 
decreasing the production of ROS or scavenging excess 
ROS have gained interest in recent years [10]. Amifostine 
specifically protects normal tissues from damage caused by 
radiation and chemotherapy [11]. In vitro and in vivo studies 
of developing cerebellar granular cells showed that amifostine 
suppressed radiation-induced cell death [2,3]. In this study, 
amifostine can significantly block the radiation-induced 
decrease of hippocampal neurogenesis in adult mice, suggesting 
amifostine protects progenitor neural cells in the adult 
hippocampus from ionizing radiation via a cytoprotective 
mechanism that includes free radical scavenging.
  Therefore, we conclude that amifostine attenuates radiation- 
induced recognition memory dysfunction in adult mice, 
possibly by inhibiting the detrimental effect of irradiation 
on hippocampal neurogenesis.
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